Scinai Immunotherapeutics Ltd. Sponsored ADR SCNI 深 沪
等待开盘 02-10 09:30:00 美东时间
0.7613
-0.070
-8.46%
华盛通- 最 高0.855
- 今 开0.855
- 成交量 5.00万股
- 最 低 0.7508
- 昨 收 0.8317
- 总市值 264.04万
- 52周最高 6.18
- 市盈率 静 0.13
- 换手率 1.44%
- 52周最低 0.613
- 委 比 0.00%
- 总股本 346.82万
- 历史最高 6200.00
- 量 比 2.53
- 振 幅 12.53%
- 历史最低 0.613
- 每 手 1
- 风险率 0.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities
Scinai Immunotherapeutics ( ($SCNI) ) has issued an announcement. On October 6,...
2025-10-06 20:20
Scinai Immunotherapeutic Awarded Grant Of About $246K From Israel Innovation Authority To Finance Project To Acquire, Install Fill-And-finish System For Sterile Manufacturing
Grant funds two-thirds of a NIS 1.23 million ($373K) project to strengthen Scinai Bioservices' small-batch fill and finish capabilities, addressing a critical need among early-stage biotech companies in Israel and
2025-10-06 19:38
Scinai Immunotherapeutics reports 1H results
Scinai Immunotherapeutics press release (NASDAQ:SCNI): 1H Revenue of $0.77M. Net loss was $4,134 thousand, compared to $4,481 thousand in the six months ended June 30, 2024, reflecting higher revenues...
2025-09-02 20:58
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Celestica Inc. (NYSE:CLS) rose sharply in pre-market trading after th...
2025-07-29 18:46
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 duri...
2025-07-02 20:06
Scinai Immunotherapeutics shares are trading higher after the company announced that it was granted clearance under the Golden Power regulation for Scinai's option to acquire 100% of the share capital and voting rights of Pincell.
Scinai Immunotherapeutics shares are trading higher after the company announced...
2025-06-05 22:37
Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth
Scinai Immunotherapeutics Ltd. Sponsored Adr ( ($SCNI) ) has released its Q4 ea...
2025-06-05 11:55
Scinai Immunotherapeutics Reports Strong CDMO Growth
Scinai Immunotherapeutics Ltd. Sponsored Adr ( ($SCNI) ) has released its Q1 ea...
2025-06-03 11:54
Scinai Immunotherapeutics reports FY results
Scinai Immunotherapeutics press release (NASDAQ:SCNI): FY Revenue of $0.65M. Financial income, net in 2024, amounted to $13.5 million compared to $3.2 million for 2023. The increase was primarily due...
2025-05-08 05:46
Scinai Announces Annual Financial Results for 2024
JERUSALEM, May 7, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing novel and innovative biol...
2025-05-08 04:01
